2023 June Inhalation HW Boston


Nathan Blazei, Head of Quality, Kymanox, has nearly two decades of life science industry experience in various quality management system tools, regulatory strategy and filings, product and process development, process validation, continuous process improvement methods, auditing and gap assessments, risk management, and regulatory inspection preparation, facilitation and remediation. Outside of Kymanox, Mr Blazei has worked for Liquidia (NC, US), Novartis Vaccines and Diagnostics (Basel, Switzerland), Grifols (Barcelona, Spain) and its predecessor Talecris Biotherapeutics, ev3 (now Covidien) (MN, US) and Boston Scientific (MA, US).

Mr Blazei holds a BSc degree in Chemical Engineering from the University of Notre Dame (IN, US) and an MEng degree in Bioengineering from the University of California, San Diego (CA, US).